Pricing Log in Create free account

Iterum Therapeutics PLC (ITRMF) vs Oragenics, Inc. (OGEN)

Iterum Therapeutics PLC and Oragenics, Inc. are both Biotechnology companies. Iterum Therapeutics PLC and Oragenics, Inc. are of similar size ($1.6M and $1.6M). Oragenics, Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 14 metrics below, Oragenics, Inc. leads on 8 and Iterum Therapeutics PLC on 6.

Valuation

Metric ITRMF OGEN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 12.53 9.40
P/B n/m 0.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 24.37 0.69 9.02
Earnings yield 0.00% (982.63%) (32.88%)
Free cash flow yield 0.00% (656.98%) (23.13%)

Profitability

Metric ITRMF OGEN Biotechnology median
Gross margin (81.85%) 19.89% 68.51%
Operating margin (2,243.48%) 0.00% 0.00%
Net margin (2,930.54%) 0.00% 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% (1,307.07%) (51.96%)
Return on assets (111.35%) (264.23%) (46.06%)
Return on invested capital (455.51%) 0.00% 0.00%

Growth

Metric ITRMF OGEN Biotechnology median
Revenue growth (TTM) — (75.08%) 6.76%
EPS growth (last fiscal year) 57.43% 90.51% 29.88%
Revenue growth, 5-year CAGR — (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ITRMF OGEN Biotechnology median
Debt to equity (2.87) 0.00 0.00
Current ratio 2.13 3.01 4.97
Net debt to EBITDA 0.24 0.98 1.01

Dividend

Metric ITRMF OGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ITRMF OGEN Biotechnology median
Market cap 1.59m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack